
### [Orphanet:79215](http://www.orpha.net/ORDO/Orphanet_79215)
**Label:** Oligosaccharidosis

**Subclasses:** [Orphanet:351](http://www.orpha.net/ORDO/Orphanet_351) (Galactosialidosis), [Orphanet:93](http://www.orpha.net/ORDO/Orphanet_93) (Aspartylglucosaminuria), [Orphanet:61](http://www.orpha.net/ORDO/Orphanet_61) (Alpha-mannosidosis), [Orphanet:3137](http://www.orpha.net/ORDO/Orphanet_3137) (Alpha-N-acetylgalactosaminidase deficiency), [Orphanet:118](http://www.orpha.net/ORDO/Orphanet_118) (Beta-mannosidosis), [Orphanet:349](http://www.orpha.net/ORDO/Orphanet_349) (Fucosidosis), 

**Corr. equiv. classes:** [Orphanet:351](http://www.orpha.net/ORDO/Orphanet_351), [OMIM:248500](http://purl.obolibrary.org/obo/OMIM_248500), [OMIM:248510](http://purl.obolibrary.org/obo/OMIM_248510), [OMIM:230000](http://purl.obolibrary.org/obo/OMIM_230000), [OMIM:208400](http://purl.obolibrary.org/obo/OMIM_208400), [Orphanet:118](http://www.orpha.net/ORDO/Orphanet_118), [Orphanet:349](http://www.orpha.net/ORDO/Orphanet_349), [Orphanet:93](http://www.orpha.net/ORDO/Orphanet_93), [Orphanet:61](http://www.orpha.net/ORDO/Orphanet_61), [Orphanet:3137](http://www.orpha.net/ORDO/Orphanet_3137), [OMIM:256540](http://purl.obolibrary.org/obo/OMIM_256540), [OMIM:609241](http://purl.obolibrary.org/obo/OMIM_609241), [OMIM:609242](http://purl.obolibrary.org/obo/OMIM_609242), 

**Class expressions from DL-Learner:**

- [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) 56.21%
- [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 56.21%
- [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 56.21%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) 56.21%
- [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) 56.21%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) 56.21%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) 56.21%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 56.21%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 56.21%
- [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) 56.21%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) 56.21%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 56.21%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 56.21%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) 56.21%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) 56.21%


